Insider Cluster (6 insiders) ·Filed Aug 20, 2026

CAH

CARDINAL HEALTH INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed1mo ago
Insider cluster: 6 insiders, $9.0M total
Actionable Insight • Neutral

The insider sales are routine and non-informative given the small proportion of market cap and the post-earnings timing. Monitor for any Form 4 filings with 10b5-1 plan designations or unusual single-day concentration; absent those, no bearish read-through is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
CAH ▼ -1.35% at T+20d
NEUTRAL call ✗ call lost -1.35% · α vs SPY -1.35% · entry $228.46 → $225.38
Next anchor: T+60d in 6w
Latest observation: T+27 -4.87% FF3 residual α
Entry anchored
Aug 19, 07:13 PM ET
via 1-min bar
T+1d
+0.46%
call +0.46% · α +0.05%
$229.51
settled 6w ago
T+5d
+2.92%
call +2.92% · α +1.80%
$235.13
settled 5w ago
T+20d
-1.35%
call -1.35% · α -1.35%
$225.38
settled 14d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Six C-suite insiders at Cardinal Health, including the CEO, CFO, and three other top executives, sold a total of $8.99M in open-market sales over a 7-day window ending 9 days after the company reported strong Q4 FY2026 earnings and announced a $5.0B buyback authorization. The cluster is large in absolute dollar terms but represents only ~0.016% of the $54.6B market cap, falling well below the 0.1% materiality threshold, and the sales follow a typical post-earnings blackout window opening pattern, making them routine and non-informative.

Key Financial Metrics

Direction
selling
Total Value
$9.0M
Insiders
6

Key Facts

  • 6 C-suite insiders sold a total of $8.99M in open-market sales over 7 days (Aug 11-18, 2026)
  • CEO Jason Hollar sold $5.02M, CFO Aaron Alt sold $731K, Chief Legal Officer Jessica Mayer sold $1.05M, and three other executives sold smaller amounts
  • Total sales represent ~0.016% of CAH's $54.6B market cap, well below the 0.1% materiality threshold
  • Sales occurred 9 days after CAH reported strong Q4 FY2026 earnings (revenue $63.7B, +6% YoY; non-GAAP EPS $2.91, +40% YoY) and announced a $5.0B incremental buyback authorization
  • No 10b5-1 plan disclosures were provided, but the timing and multi-executive pattern are consistent with post-earnings blackout window opening

Financial Impact

Total insider sales of $8.99M, or ~0.016% of market cap — immaterial relative to company size

insider ownership

Risk Factors

  • Insider sales could be misinterpreted as a bearish signal by the market despite their routine nature
  • If future filings reveal undisclosed negative developments (e.g., guidance revision, regulatory action), the sales could be viewed as opportunistic in hindsight

Market Snapshot

Exchange
NYSE
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
87% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CAH-1787227851823
8 reports for CAH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CAH — sortable, filterable
TypeNow
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$228.46 $225.38▼ −1.35%▼ −1.35%$230.09 (+0.71%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$228.46 $225.38▼ −1.35%▼ −1.35%$230.09 (+0.71%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$228.46 $225.38▼ −1.35%▼ −1.35%$230.09 (+0.71%)
Aug 11, 2026
7w ago
8-K
BULLISH ★ 7/10
$240.26 $239.92▼ −0.14%▲ +0.92%$230.09 (−4.23%)
Aug 11, 2026
7w ago
8-K
NEUTRAL ★ 4/10
$240.26 $239.92▼ −0.14%▲ +0.92%$230.09 (−4.23%)
Aug 5, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$239.23 $245.49▲ +2.62%▲ +3.22%$230.09 (−3.82%)
Jul 20, 2026
10w ago
Press Release
NEUTRAL ★ 5/10
$227.09 $234.98▲ +3.47%▲ +0.91%$230.09 (+1.32%)
Mar 5, 2026
30w ago
8-K
NEUTRAL ★ 3/10
$215.96 $214.02▼ −0.90%▲ +2.89%$230.09 (+6.54%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 1h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 20, 2026